Alfresa Holdings Corporation (TYO:2784)

Market Cap	415.73B
Revenue (ttm)	3.00T
Net Income (ttm)	27.96B
Shares Out	181.90M
EPS (ttm)	151.66
PE Ratio	15.07
Forward PE	13.75
Dividend	68.00 (2.98%)
Ex-Dividend Date	Sep 29, 2025

Volume	292,900
Average Volume	336,840
Open	2,259.50
Previous Close	2,285.50
Day's Range	2,230.50 - 2,265.50
52-Week Range	1,897.00 - 2,388.00
Beta	-0.12
RSI	60.35
Earnings Date	Nov 6, 2025

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, and pharmacies. In addition, it manu...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,452
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2784

Financial Performance

In 2024, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.